Pilot Study: Hypovitaminosis D, Hyperparathyroidism and Hypomagnesemia in Patients With Congestive Heart Failure

The recruitment status of this study is unknown because the information has not been verified recently.

Verified April 2009 by State University of New York - Downstate Medical Center.
Recruitment status was Recruiting

Sponsor:

Information provided by:

State University of New York - Downstate Medical Center

ClinicalTrials.gov Identifier:

NCT00887666

First received: April 23, 2009

Last updated: NA

Last verified: April 2009

History: No changes posted

Tracking Information

First Received Date ^ICMJE

April 23, 2009

Last Updated Date

April 23, 2009

Start Date ^ICMJE

October 2007

Primary Completion Date

Not Provided

Current Primary Outcome Measures ^ICMJE

Prevalence of hypovitaminosis D, Hyperparathyroidism, Hypomagnesemia in our cohort of CHF patients [ Time Frame: One year ] [ Designated as safety issue: No ]

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

No Changes Posted

Current Secondary Outcome Measures ^ICMJE

Not Provided

Original Secondary Outcome Measures ^ICMJE

Not Provided

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Pilot Study: Hypovitaminosis D, Hyperparathyroidism and Hypomagnesemia in Patients With Congestive Heart Failure

Official Title ^ICMJE

Pilot Study: Hypovitaminosis D, Hyperparathyroidism and Hypomagnesemia in Patients With Congestive Heart Failure

Brief Summary

People with heart failure may have low magnesium and low vitamin D levels. They may also have abnormally high levels of parathyroid hormones. Magnesium and vitamin D are important chemicals that are not routinely measured in blood tests. We are studying how many people with heart failure have low levels of magnesium and vitamin D. We are also studying how many people with heart failure have overactive parathyroid glands and if that is related to their vitamin D levels.

Detailed Description

Not Provided

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Observational Model: Cohort
Time Perspective: Prospective

Target Follow-Up Duration

Not Provided

Biospecimen

Not Provided

Sampling Method

Probability Sample

Study Population

People with congestive heart failure

Condition ^ICMJE

Congestive Heart Failure
Hypovitaminosis D
Hypomagnesemia
Hyperparathyroidism

Intervention ^ICMJE

Not Provided

Study Group/Cohort (s)

Not Provided

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Recruiting

Estimated Enrollment ^ICMJE

Completion Date

Not Provided

Primary Completion Date

Not Provided

Eligibility Criteria ^ICMJE

Inclusion Criteria:

congestive heart failure

Exclusion Criteria:

pregnant
hospitalized within one month
taking calcium, vitamin D or magnesium supplements
proteinuria > 1g/24h
creatinine clearance <35 (MDRD)

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact: Sima Terebelo, MPH, RPA-C

718-270-8216

sima.terebelo@downstate.edu

Location Countries ^ICMJE

United States

Administrative Information

NCT Number ^ICMJE

NCT00887666

Other Study ID Numbers ^ICMJE

07-121

Has Data Monitoring Committee

Responsible Party

Mariana Markell, MD, SUNY Downstate Medical Center

Study Sponsor ^ICMJE

State University of New York - Downstate Medical Center

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Principal Investigator:

Mariana Markell, MD

State University of New York - Downstate Medical Center

Information Provided By

State University of New York - Downstate Medical Center

Verification Date

April 2009

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top